Unfortunately, my initial hands-on testing with corrupted datasets reveals a fundamental enterprise problem: impressive capabilities paired with insufficient transparency about data transformations.

In this valuable study, the authors provide a simple yet elegant approach to identifying therapeutic targets that synergize to prevent therapeutic resistance in ovarian cancer using cell lines, ...